High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.5M
$1,509,740
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALKS
M
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
Other
2026-03-02
$96,700
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
Other
|
2026-03-02 | $96,700 | M | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
2026-03-02
$267,485
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
|
2026-03-02 | $267,485 | S | Form 4 |
|
ALKS
M
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
Other
2026-02-02
$96,700
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
Other
|
2026-02-02 | $96,700 | M | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
2026-02-02
$305,384x2
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
|
2026-02-02 | $305,384x2 | S | Form 4 |
|
ALKS
M
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
Equity Compensation
2026-01-08
$96,700x2
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
Equity Compensation
|
2026-01-08 | $96,700x2 | M | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
2026-01-08
$150,005
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
|
2026-01-08 | $150,005 | S | Form 4 |
|
ALKS
M
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
Equity Compensation
2025-12-03
$72,486x2
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
Equity Compensation
|
2025-12-03 | $72,486x2 | M | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
2025-12-03
$112,447
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
|
2025-12-03 | $112,447 | S | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
2025-12-01
$117,200
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
|
2025-12-01 | $117,200 | S | Form 4 |
|
ALKS
M
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
Other
2025-11-03
$96,700
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
Other
|
2025-11-03 | $96,700 | M | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 SellΔOwn -11.4%
2025-11-03
$273,442
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 SellΔOwn -11.4%
|
2025-11-03 | $273,442 | S | Form 4 |
|
ALKS
M
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
Other
2025-10-15
$96,700
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
Other
|
2025-10-15 | $96,700 | M | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 SellΔOwn -10.9%
2025-10-15
$283,776
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 SellΔOwn -10.9%
|
2025-10-15 | $283,776 | S | Form 4 |